BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6304545)

  • 1. [Prognosis of glioblastoma multiforme today].
    Neumann J
    Nervenarzt; 1983 Apr; 54(4):191-3. PubMed ID: 6304545
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgifoam and mitoxantrone in the glioblastoma multiforme postresection cavity: the first step of locoregional chemotherapy through an ad hoc-placed catheter: technical note.
    Ferroli P; Broggi M; Franzini A; Maccagnano E; Lamperti M; Boiardi A; Broggi G
    Neurosurgery; 2006 Aug; 59(2):E433-4; discussion E433-4. PubMed ID: 16883158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glioblastoma multiforme. Postoperative therapy].
    Fischer J; Kostron H
    ZFA (Stuttgart); 1983 Feb; 59(5):232-3. PubMed ID: 6301165
    [No Abstract]   [Full Text] [Related]  

  • 5. Glioblastoma multiforme-report of 267 cases treated at a single institution.
    Stark AM; Nabavi A; Mehdorn HM; Blömer U
    Surg Neurol; 2005 Feb; 63(2):162-9; discussion 169. PubMed ID: 15680662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).
    Combs SE; Widmer V; Thilmann C; Hof H; Debus J; Schulz-Ertner D
    Cancer; 2005 Nov; 104(10):2168-73. PubMed ID: 16220556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of postoperative radiation therapy of glioblastoma multiforme in relation to dose distribution].
    Ragaĭshene VN
    Med Radiol (Mosk); 1974 May; 19(5):47-53. PubMed ID: 4368115
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
    Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
    Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.
    Odrazka K; Petera J; Kohlova T; Dolezel M; Vaculikova M; Zouhar M; Malek V; Hobza V; Latr I; Nemecek S; Sercl M; Ryska P; Blaha M; Cermakova E
    Strahlenther Onkol; 2003 Sep; 179(9):615-9. PubMed ID: 14628127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical treatment and radiation therapy for glioblastoma multiforme, with special reference to intraoperative radiotherapy].
    Matsutani M; Matsuda T; Nagashima T; Kohno T; Hoshino T; Terao H
    Gan No Rinsho; 1984 Apr; 30(4):325-33. PubMed ID: 6328061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgery of glioblastoma multiforme and its follow-up results].
    Matsukado Y; Kitamura K
    No To Shinkei; 1967 Dec; 19(12):1251-7. PubMed ID: 4296379
    [No Abstract]   [Full Text] [Related]  

  • 12. The glioblastoma multiforme: a lifelong challenge to the neurosurgeon.
    Heppner F
    Neurochirurgia (Stuttg); 1986 Jan; 29(1):9-14. PubMed ID: 3008012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination treatment of malignant brain tumors. Results of initial experiences].
    Bauer B; Adrian G
    Psychiatr Neurol Med Psychol (Leipz); 1983 Sep; 35(9):566-73. PubMed ID: 6316389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Communicating hydrocephalus occurring in the postoperative course of glioblastoma multiforme.
    Ando S; Moritake K
    Nihon Geka Hokan; 1989 Nov; 58(6):508-15. PubMed ID: 2562400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of the fatal cases of adult malignant gliomas after aggressive treatment].
    Takamura Y; Ibayashi Y; Morimoto S; Tanabe S; Hashi K
    No Shinkei Geka; 1994 Mar; 22(3):207-13. PubMed ID: 8133960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case 5: altered mental status and fever after resection of glioblastoma multiforme.
    Blakeley J; Geocadin R
    MedGenMed; 2004 Apr; 6(2):49. PubMed ID: 15266274
    [No Abstract]   [Full Text] [Related]  

  • 18. The survival impact of postoperative infection in patients with glioblastoma multiforme.
    Bohman LE; Gallardo J; Hankinson TC; Waziri AE; Mandigo CE; McKhann GM; Sisti MB; Canoll P; Bruce JN
    Neurosurgery; 2009 May; 64(5):828-34; discussion 834-5. PubMed ID: 19404146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Recurrent' glioblastoma multiforme, when should we reoperate?
    Barbagallo GM; Jenkinson MD; Brodbelt AR
    Br J Neurosurg; 2008 Jun; 22(3):452-5. PubMed ID: 18568742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study.
    Welsh J; Sanan A; Gabayan AJ; Green SB; Lustig R; Burri S; Kwong E; Stea B
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):159-65. PubMed ID: 17331666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.